21SHARES LAUNCHES INJECTIVE ETP WITH STAKING ON EURONEXT

Last updated: June 19, 2025, 19:35 | Written by: Cameron Winklevoss

The world of cryptocurrency investments is constantly evolving, and a significant step towards mainstream adoption has been taken with the launch of the 21Shares Injective Staking Exchange Traded Product (ETP) on Euronext Paris and Amsterdam. INJ takes a spot among the largest cryptos with a financial product exposing it to traditional investors.Continue reading 21Shares launches Injective ETP with staking on Euronext TheThis innovative financial instrument provides investors with an accessible and regulated way to gain exposure to Injective (INJ), a decentralized blockchain designed for financial applications. ZURICH, 21Shares AG ( 21Shares ), one of the world s largest issuers of crypto exchange traded products (ETPs), today announced the launch of the 21Shares Immutable ETP (AIMX), the 21Shares Injective Staking ETP (AINJ) and the 21Shares Sui Staking ETP (ASUI) on Euronext Paris and Euronext Amsterdam. AIMX, AINJ and ASUIWhat makes this ETP particularly attractive is its integration of staking rewards, offering investors not only exposure to the price movements of INJ but also a yield generated by participating in the network's validation process.This move by 21Shares marks a pivotal moment, bringing decentralized finance (DeFi) closer to traditional financial markets and potentially unlocking significant institutional investment in the Injective ecosystem.With the AINJ ETP now available on major brokerages like Saxo Bank, Swissquote, and eToro, the barriers to entry for traditional investors are significantly lowered, paving the way for a broader audience to participate in the exciting world of crypto investing. 21Shares has launched Injective Protocol ETP which will trade on Euronext Paris (AINJ FP) and Euronext Amsterdam (AINJ NA). AINJ will be available on more than 40 brokers including Saxo Bank, Swissquote and eToro. The Injective Protocol ETP is likely to lead to a surge in institutional investment in INJ. IntroductionThis development positions Injective among the leading cryptocurrencies with financial products that cater to a more conventional investment approach, signaling a growing maturity in the digital asset space.

What is the 21Shares Injective Staking ETP (AINJ)?

The 21Shares Injective Staking ETP, trading under the ticker AINJ, is an Exchange Traded Product designed to track the performance of the Injective (INJ) cryptocurrency.What distinguishes it from a simple tracker fund is its incorporation of staking rewards.This means that investors not only benefit from potential price appreciation of INJ but also receive a yield generated from staking their holdings within the Injective network.

Here's a breakdown of the key features:

Ticker Symbols: AINJ FP (Euronext Paris) and AINJ NA (Euronext Amsterdam)
Underlying Asset: Injective (INJ) cryptocurrency
Staking Rewards: Captures staking yields, which are reinvested into the ETP for enhanced performance.
Physical Backing: 100% physically backed by INJ tokens held in cold storage by a custodian, ensuring security and transparency.
Accessibility: Available on major brokerages like Saxo Bank, Swissquote, and eToro.

How Does Staking Work in the AINJ ETP?

Staking is the process of holding cryptocurrency in a wallet to support the operations of a blockchain network and earn rewards in return.In the case of the 21Shares Injective Staking ETP, the underlying INJ tokens are staked on the Injective network. 21Shares launches Injective ETP with staking on Euronext . Derek Andersen21Shares launches Injective ETP with staking on EuronextINJ takes a spot among the largest cryptos with a financial product exposing it to traditional investors.998 Total views1 Total sharesListen to article 0:00NewsOwn this piece of crypto historyCollect this article as NFTJoin us on social networksAssetThe rewards generated from this staking activity are then reinvested back into the ETP, increasing the overall value of the fund.

This process offers a significant advantage to investors as it allows them to earn passive income on their INJ holdings without having to actively manage the staking process themselves. 21Shares handles all the complexities of staking, making it a hassle-free way for investors to participate in the Injective network and earn rewards.

Why is the Launch of AINJ Significant?

The launch of the 21Shares Injective Staking ETP is a significant development for several reasons:

Mainstream Adoption: It brings cryptocurrency investment closer to traditional finance, making it easier for institutional and retail investors to gain exposure to INJ through regulated exchanges and brokerages.
Increased Liquidity: The ETP provides increased liquidity for INJ, as it can be easily bought and sold on Euronext exchanges.
Institutional Investment: It's likely to lead to a surge in institutional investment in INJ, as it provides a familiar and regulated investment vehicle for institutions that may be hesitant to directly hold cryptocurrencies.
Simplified Staking: It simplifies the process of staking INJ, allowing investors to earn rewards without having to manage their own wallets and staking infrastructure.
Enhanced Performance: The reinvestment of staking rewards into the ETP enhances the overall performance of the fund.

By bridging the gap between traditional finance and the world of decentralized finance, the AINJ ETP has the potential to significantly expand the reach of Injective and contribute to the overall growth of the cryptocurrency market.

Understanding Injective Protocol and its Significance

To fully appreciate the significance of the 21Shares Injective Staking ETP, it's crucial to understand the Injective Protocol itself.Injective is a decentralized blockchain specifically designed for financial applications. Asset manager 21Shares has launched an Injective exchange-traded product (ETP) on Euronext exchanges. Injective thus joins a small group of cryptos available to investors through traditional financialIt differentiates itself from other blockchain networks through its unique features and capabilities.

Key features of Injective Protocol include:

Decentralized Exchange (DEX) Infrastructure: Injective provides a robust and secure infrastructure for building and operating decentralized exchanges.
Cross-Chain Interoperability: Injective supports seamless interactions across major blockchain networks, enabling a wide range of financial products and services.This interoperability allows users to trade assets from different blockchains on a single platform.
Zero Gas Fees: Injective offers a zero gas fee environment for traders, making it more cost-effective to participate in decentralized finance.
Instant Finality: Injective achieves instant finality for transactions, providing a faster and more reliable trading experience.
Built for Finance: The protocol is specifically designed to support complex financial applications, such as derivatives trading, prediction markets, and lending platforms.

Injective's unique architecture and features make it a powerful platform for building innovative financial applications.The launch of the 21Shares Injective Staking ETP is a testament to the growing recognition of Injective's potential within the financial industry.

How to Invest in the 21Shares Injective Staking ETP (AINJ)

Investing in the 21Shares Injective Staking ETP is relatively straightforward, especially for those already familiar with investing in traditional financial products.Here's a step-by-step guide:

Choose a Broker: Select a broker that offers access to Euronext Paris or Euronext Amsterdam, where the AINJ ETP is listed. INJ f r en plass blant de st rste kryptovalutaene med et finansielt produkt som gir eksponering til tradisjonelle investorer. Aktivaforvalteren 21Shares har lansert et Injective b rsnotertPopular options include Saxo Bank, Swissquote, and eToro.
Open an Account: Open an investment account with your chosen broker.You'll need to provide personal information and comply with the broker's KYC (Know Your Customer) requirements.
Fund Your Account: Deposit funds into your account using your preferred payment method, such as bank transfer or credit card.
Search for AINJ: Use the broker's search function to find the 21Shares Injective Staking ETP by its ticker symbol (AINJ FP for Euronext Paris or AINJ NA for Euronext Amsterdam).
Place Your Order: Enter the number of shares you want to purchase and place your order. 21Shares AG has announced the launch of the 21Shares Immutable ETP (AIMX), the 21Shares Injective Staking ETP (AINJ) and the 21Shares Sui Staking ETP (ASUI) on Euronext Paris and Euronext Amsterdam.You can choose between a market order (to buy at the current market price) or a limit order (to buy at a specific price).
Monitor Your Investment: Once your order is executed, you can monitor the performance of your investment through your broker's platform.

Important Considerations Before Investing

Before investing in any cryptocurrency-related product, it's important to carefully consider the risks involved.Here are some key considerations for the 21Shares Injective Staking ETP:

Volatility: Cryptocurrencies are highly volatile assets, and the price of INJ can fluctuate significantly. 100% physically-backed, the 21Shares Injective Staking ETP (AINJ) tracks the performance of INJ while capturing staking yields that are reinvested into the ETP for enhanced performance. Whereas blockchain networks are typically siloed, Injective Protocol supports seamless interactions across major networks, enabling a unique range of financial products and services. The 21Shares InjectiveBe prepared for potential losses.
Regulatory Risk: The regulatory landscape for cryptocurrencies is constantly evolving.Changes in regulations could impact the value of INJ and the ETP.
Staking Risks: While staking can provide rewards, there are also risks involved, such as the potential for slashing (loss of staked tokens) if the network detects malicious behavior.
Custodial Risk: While the INJ tokens are held in cold storage by a custodian, there is always a risk of theft or loss due to unforeseen circumstances.
Fee Structure: Be aware of the fees associated with the ETP, such as the management fee.In the case of AINJ, the fee is 2.5%. 21Shares Injective Staking ETP. 21Shares lists its first product on Euronext Amsterdam and Paris. 21Shares launches its 30th product CBTC, on the SIX SwissThese fees can impact your overall returns.

It's essential to conduct thorough research and understand the risks before investing in the 21Shares Injective Staking ETP or any other cryptocurrency-related product.Consider consulting with a financial advisor to determine if this investment is suitable for your individual circumstances.

The Broader Impact: ETPs and the Future of Crypto Investing

The launch of the 21Shares Injective Staking ETP is part of a broader trend towards the increasing institutionalization of cryptocurrency investing. Asset manager 21Shares has launched an Injective exchange-traded product (ETP) on Euronext exchanges. Injective thus joins a small group of cryptos available to investors through traditional financial products.Exchange Traded Products (ETPs) like AINJ play a crucial role in this process by providing a regulated and accessible way for traditional investors to participate in the crypto market.

Here are some of the key benefits of ETPs for the crypto industry:

Increased Accessibility: ETPs make it easier for a wider range of investors to access cryptocurrencies through familiar investment platforms.
Regulatory Oversight: ETPs are subject to regulatory oversight, providing investors with a greater level of protection compared to directly holding cryptocurrencies.
Simplified Investing: ETPs simplify the process of investing in cryptocurrencies, eliminating the need for investors to manage their own wallets and keys.
Diversification: ETPs can allow investors to diversify their portfolios by adding exposure to cryptocurrencies without having to directly purchase and store them.

As the cryptocurrency market continues to mature, we can expect to see even more ETPs and other traditional financial products emerge, further blurring the lines between traditional finance and decentralized finance.

21Shares' Expansion: Immutable and Sui Staking ETPs

The launch of the Injective Staking ETP (AINJ) is not an isolated event. News Summary: Asset manager 21Shares has launched an Injective exchange-traded product (ETP) on Euronext exchanges. Injective thus joins a small group of cryptos available to investors through traditional financial products. INJ takes a spot among the largest cryptos with a financial product exposing it to traditional investors. The Injective Staking Exchange Traded Product (AINJ) will trackAsset manager 21Shares has also introduced the 21Shares Immutable ETP (AIMX) and the 21Shares Sui Staking ETP (ASUI) on Euronext Paris and Amsterdam. 21Shares has unveiled its latest crypto product, the Injective Staking Exchange-Traded Product (ETP) AINJ. This product aims to enable investors to engage in the crypto market via traditional financial avenues. Investors will also get exposure to Injective staking rewards. Is an Injective Exchange-Traded Fund (ETF) on the Horizon?This simultaneous launch of three new crypto ETPs demonstrates 21Shares' commitment to expanding its offerings and providing investors with a diverse range of options for accessing the cryptocurrency market.

Each of these ETPs focuses on a different blockchain project and offers unique features:

21Shares Immutable ETP (AIMX): Provides exposure to the Immutable X blockchain, a Layer-2 scaling solution for NFTs on Ethereum.
21Shares Injective Staking ETP (AINJ): As discussed, this ETP tracks the performance of Injective (INJ) and captures staking yield.
21Shares Sui Staking ETP (ASUI): Offers exposure to the Sui blockchain, a new Layer-1 blockchain designed for scalability and high throughput.

By launching these three new ETPs, 21Shares is catering to a wider range of investor interests and providing exposure to different segments of the cryptocurrency market, including DeFi, NFTs, and Layer-1 blockchains.

Potential Challenges and Considerations

While the 21Shares Injective Staking ETP offers several advantages, it's essential to acknowledge potential challenges and considerations:

Market Volatility: The cryptocurrency market is known for its volatility.INJ's price could experience significant fluctuations, impacting the ETP's performance.
Staking Risks: Although the ETP handles staking, inherent risks like slashing or validator downtime can affect staking rewards.
Regulatory Changes: Cryptocurrency regulations are still evolving.New regulations could potentially impact the ETP's operations or value.
Adoption Rate: The success of the ETP depends on investor adoption.Muted market response could limit its growth.

Investors should carefully weigh these factors before investing in the AINJ ETP.Diversification and a long-term investment horizon can help mitigate some of these risks.

Conclusion: A Step Forward for Crypto Investment

The launch of the 21Shares Injective Staking ETP (AINJ) on Euronext marks a significant milestone in the evolution of cryptocurrency investment.By providing a regulated, accessible, and yield-bearing investment vehicle, 21Shares is bringing decentralized finance closer to the mainstream.This ETP simplifies the process of investing in Injective (INJ) and earning staking rewards, making it easier for both institutional and retail investors to participate in the Injective ecosystem.The AINJ ETP is a testament to the growing maturity of the cryptocurrency market and the increasing demand for regulated and transparent investment products.While risks remain, the potential benefits of increased accessibility, liquidity, and institutional investment make this a noteworthy development for the entire crypto industry. Injective Labs, in collaboration with 21Shares, has announced the launch of AINJ the Injective Staking Exchange-Traded Product (ETP) linked to INJ, which will include staking. The fund will allow users to gain exposure to INJ tokens via major traditional financial exchanges and brokerages while also capturing staking rewards. The ETP will trade on Euronext [ ] source:As the cryptocurrency market continues to evolve, products like the 21Shares Injective Staking ETP will play a crucial role in bridging the gap between traditional finance and the exciting world of decentralized finance. The Injective Staking Exchange Traded Product (AINJ) will track the performance of Injective (INJ) and capture staking yield for reinvestment in the ETP. Injective is a decentralized blockchain designed for financial applications. The ETP will be physically backed by INJ kept in cold storage by a custodian.Is the Injective Exchange-Traded Fund (ETF) on the Horizon? The Injective Staking Exchange Traded Product (AINJ) will track the performance of Injective and capture staking yield for reinvestment in the ETP. Injective is a decentralized blockchain designed for financial applications. The ETP will be physically backed by INJ kept in cold storage by a custodian.Only time will tell, but the launch of AINJ is a strong step in that direction.

Key Takeaways:

The 21Shares Injective Staking ETP (AINJ) provides investors with exposure to Injective (INJ) and staking rewards through traditional financial markets.
It's available on Euronext Paris and Amsterdam, making it accessible to a wide range of investors.
The ETP is 100% physically backed by INJ tokens held in cold storage.
The launch of AINJ is a significant step towards the mainstream adoption of cryptocurrencies.
Investors should carefully consider the risks involved before investing in the AINJ ETP.

Call to Action:

Interested in learning more about the 21Shares Injective Staking ETP (AINJ)?Visit the 21Shares website or contact your financial advisor for more information.